Heart rate variability in idiopathic dilated cardiomyopathy: Relation to disease severity and prognosis

被引:67
作者
Yi, G
Goldman, JH
Keeling, PJ
Reardon, M
McKenna, WJ
Malik, M
机构
[1] Department of Cardiological Sciences, St. George's Hospital Medical School, London
[2] Department of Cardiological Sciences, St. George's Hospital Medical School, London SW17 0RE, Cranmer Terrace
关键词
heart rate variability; idiopathic dilated cardiomyopathy; progressive heart failure; left ventricular enlargement;
D O I
10.1136/hrt.77.2.108
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To assess the clinical importance of heart rate variability (HRV) in patients with idiopathic dilated cardiomyopathy (DCM). Patients and methods-Time domain analysis of 24 hour HRV was performed in 64 patients with DCM, 19 of their relatives with left ventricular enlargement (possible early DCM), and 33 healthy control subjects. Results-Measures of HRV were reduced in patients with DCM compared with controls (P < 0 . 05). HRV parameters were similar in relatives and controls. Measures of HRV were lower in DCM patients in whom progressive heart failure developed (n = 28) than in those who remained clinically stable (n = 36) during a follow up of 24 (20) months (P = 0 . 0001). Reduced HRV was associated with NYHA functional class, left ventricular end diastolic dimension, reduced left ventricular ejection fraction, and peak exercise oxygen consumption (P < 0 . 05) in all patients. DCM patients with standard deviation of normal to normal RR intervals calculated over the 24 hour period (SDNN) < 50 ms had a significantly lower survival rate free of progressive heart failure than those with SDNN > 50 ms (P = 0 . 0002, at 12 months; P = 0 . 0001, during overall follow up). Stepwise multiple regression analysis showed that SDNN < 50 ms identified, independently of other clinical variables, patients who were at increased risk of developing progressive heart failure (P = 0 . 0004). Conclusions-HRV is reduced in patients with DCM and related to disease severity. HRV is clinically useful as an early noninvasive marker of DCM deterioration.
引用
收藏
页码:108 / 114
页数:7
相关论文
共 27 条
[1]   AUTONOMIC NERVOUS-SYSTEM ACTIVITY IN IDIOPATHIC DILATED CARDIOMYOPATHY AND IN HYPERTROPHIC CARDIOMYOPATHY [J].
AJIKI, K ;
MURAKAWA, Y ;
YANAGISAWAMIWA, A ;
USUI, M ;
YAMASHITA, T ;
OIKAWA, N ;
INOUE, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (15) :1316-1320
[2]  
AMORIM DS, 1981, LANCET, V1, P525
[3]  
Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3
[4]   FREQUENCY-DOMAIN MEASURES OF HEART PERIOD VARIABILITY AND MORTALITY AFTER MYOCARDIAL-INFARCTION [J].
BIGGER, JT ;
FLEISS, JL ;
STEINMAN, RC ;
ROLNITZKY, LM ;
KLEIGER, RE ;
ROTTMAN, JN .
CIRCULATION, 1992, 85 (01) :164-171
[5]  
Camm AJ, 1996, CIRCULATION, V93, P1043
[6]   DECREASED SPONTANEOUS HEART-RATE VARIABILITY IN CONGESTIVE HEART-FAILURE [J].
CASOLO, G ;
BALLI, E ;
TADDEI, T ;
AMUHASI, J ;
GORI, C .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (18) :1162-1167
[7]   HEART-RATE-VARIABILITY AND FUNCTIONAL SEVERITY OF CONGESTIVE-HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE [J].
CASOLO, GC ;
STRODER, P ;
SULLA, A ;
CHELUCCI, A ;
FRENI, A ;
ZERAUSCHEK, M .
EUROPEAN HEART JOURNAL, 1995, 16 (03) :360-367
[8]   HEART-RATE-VARIABILITY DURING THE ACUTE PHASE OF MYOCARDIAL-INFARCTION [J].
CASOLO, GC ;
STRODER, P ;
SIGNORINI, C ;
CALZOLARI, F ;
ZUCCHINI, M ;
BALLI, E ;
SULLA, A ;
LAZZERINI, S .
CIRCULATION, 1992, 85 (06) :2073-2079
[9]   DEFECTIVE CARDIAC PARASYMPATHETIC CONTROL IN PATIENTS WITH HEART DISEASE [J].
ECKBERG, DL ;
DRABINSKY, M ;
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (16) :877-+
[10]   ASSESSMENT OF CARDIOVASCULAR EFFECTS IN DIABETIC AUTONOMIC NEUROPATHY AND PROGNOSTIC IMPLICATIONS [J].
EWING, DJ ;
CAMPBELL, IW ;
CLARKE, BF .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (02) :308-311